Physician Assistant · Oklahoma City, OK
NPI
1558332981
Since 2006
Specialty
Physician Assistant
Code 363A00000X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
6205 N Santa Fe Ave Ste 200
Oklahoma City, OK, 73118
Phone (405) 231-8740
Groups this clinician bills Medicare through
Medicare paid, 2024
$47K
1,259 services
Medicare patients, 2024
286
Average age 70
Drug cost, 2024
$3.2M
4,531 prescriptions
Company payments, 2025
$3,073
From 28 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Andrea D Moser was code 99214 (office e&m - established), 649 times for 271 patients. In total Andrea D Moser billed 1,259 services in 7 codes, and Medicare paid $47K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-02-20.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 649 | 271 | $55.95 | $36K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 299 | 152 | $9.92 | $2,965 |
| 95251 Test - Miscellaneous | Office | 268 | 113 | $20.58 | $5,516 |
| 99213 Office E&M - Established | Office | 20 | 18 | $37.54 | $751 |
| 99204 Office E&M - New | Office | 11 | 11 | $68.88 | $758 |
| 99215 Office E&M - Established | Office | 11 | 11 | $86.34 | $950 |
By year: 2022 $58K for 1,826 services; 2023 $57K for 1,769 services; 2024 $47K for 1,259 services.
Lab tests billed to Medicare, 2023
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 82962 Clinical Chemistry | 493 | 214 | $3.15 | $1,551 |
| 83036 Blood Count | 403 | 203 | $9.35 | $3,767 |
Medicare prescription drug claims, 2024
In 2024, the drug Andrea D Moser prescribed most often to Medicare patients was Ozempic (Semaglutide), with 393 prescriptions and refills. In total Andrea D Moser wrote 4,531 Medicare prescriptions that cost $3.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ozempic Semaglutide | 393 | 720 | 106 | $655K |
| Jardiance Empagliflozin | 365 | 773 | 88 | $439K |
| Levothyroxine Sodium Generic | 311 | 786 | 87 | $3,661 |
| Mounjaro Tirzepatide | 306 | 511 | 59 | $547K |
| Tresiba Flextouch U-200 Insulin Degludec | 228 | 564 | 72 | $269K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 160 | 401 | 51 | $29K |
| Metformin Hcl Er Metformin Hcl | 136 | 378 | 38 | $1,616 |
| Metformin Hcl Generic | 127 | 360 | 42 | $1,480 |
| Glimepiride Generic | 123 | 333 | 37 | $1,538 |
| Rosuvastatin Calcium Generic | 113 | 314 | 39 | $1,632 |
| Novolog Flexpen Insulin Aspart | 112 | 243 | 47 | $38K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 93 | 259 | 45 | $13K |
| Farxiga Dapagliflozin Propanediol | 92 | 201 | 25 | $108K |
| Humulin R U-500 Kwikpen Insulin Regular, Human | 76 | 124 | 17 | $134K |
| Humalog Kwikpen U-100 Insulin Lispro | 73 | 171 | 29 | $30K |
Brand drugs: 2,882 claims; generic drugs: 1,300 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Andrea D Moser $3,073 ($3,073 in general payments such as food, travel and fees) from 28 companies. The largest payer was Xeris Pharmaceuticals, Inc. with $267.
| Company | Payments | Amount |
|---|---|---|
| Xeris Pharmaceuticals, Inc. | 15 | $267 |
| Dexcom, Inc. DXCM | 18 | $264 |
| Corcept Therapeutics CORT | 13 | $247 |
| Abbott Laboratories ABT | 6 | $247 |
| Novo Nordisk Inc NVO | 13 | $202 |
| Sequel Med Tech, LLC | 10 | $183 |
| Sanofi-Aventis U.S. LLC SNY | 8 | $179 |
| Tandem Diabetes Care, Inc. TNDM | 8 | $168 |
| Amgen Inc. AMGN | 11 | $162 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 13 | $154 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.